About CellAegis Devices
CellAegis Devices is a Healthcare company based in Mississauga (Canada) founded in 2009. Non-invasive automated device for chronic remote ischemic conditioning is developed. CellAegis Devices has raised $19.13 million across 6 funding rounds from investors including CTI Life Sciences, MaRS Catalyst Fund and Broadview Ventures. Its Indian entity Ironsource India Private Limited reported revenue of ₹21.75 Cr. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices.
Company details
CellAegis Devices was founded in 2009 in Mississauga, Canada, within the medical devices sector focused on cardiology. The autoRIC device is being developed as a portable tool for delivering chronic remote ischemic conditioning to patients post-acute myocardial infarction or during cardiothoracic procedures. Point-of-care application is enabled for adults over 18. CE Mark and Health Canada approvals have been obtained, while investigational status is held in the US as of 2018.
- Headquarters Mississauga, Canada
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website cellaegis.com
- Social LinkedIn
- Legal Name Ironsource India Private Limited
- Date of Incorporation 26 Apr, 2016
- Jurisdiction Bangalore, Karnataka, India
- Indian entity revenue₹21.75 Cr
FY 2025 · +206% YoY
- Indian entity net profit₹3.79 Cr
FY 2025 · 17% margin
- Indian entity EBITDA₹5.88 Cr
FY 2025 · 27% margin
- Total Equity Funding$19.13M (USD)
in 6 rounds
- Latest Funding Round$9.5M (USD), Series C
Mar 2017
- InvestorsCTI Life Sciences
& 2 more
Associated legal entities of CellAegis Devices
CellAegis Devices operates through Ironsource India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Ironsource India Private Limited CIN U74300KA2016FTC092539 | Active | 26 Apr 2016 | Bangalore, Karnataka | ₹21.7 Cr | 21 | 4 | View details |
Funding Insights of CellAegis Devices
CellAegis Devices has successfully raised a total of $19.13M across 6 strategic funding rounds. The most recent funding activity was a Series C round of $9.5 million completed in March 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $19.13M
- Total Rounds 6
- Last Round Series C — $9.5M
- First Round $23,693
(Mar 2013)
- Investors Count 3
All 6 funding rounds of CellAegis Devices with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2017 | $9.5M | Series C | – | – | |
| Mar 2017 | $9.5M | Series C | – | CTI Life Sciences Fund | |
| May 2016 | $81,108 | Series A | – | – | – |
| Jul 2013 | Seed | – | – | – | |
| Apr 2013 | $23,693 | Seed | – | – | – |
| Mar 2013 | $23,693 | Seed | – | – | – |
3 investors in total: 3 institutional.
Investors in CellAegis Devices
CellAegis Devices has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include CTI Life Sciences, MaRS Catalyst Fund and Broadview Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investments are made in life sciences companies. | ctisciences.com | Montreal, Canada | ||
| marscatalystfund.com | ||||
Seed-stage life sciences investments are made in the US. | broadviewventures.org | Boston, United States |
Investor details for CellAegis Devices
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Ironsource India Private Limited (CellAegis Devices)
Ironsource India Private Limited is the primary company behind CellAegis Devices. The board of Ironsource India Private Limited currently have 4 directors; the longest-serving is Nora Sen Go, appointed in 2024. 8 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Nora Sen Go DIN 10531941 | Director | 04 Mar 2024 | 2 yrs 8 mo | Ironsource India Private Limited |
| Bhagavant Bedi DIN 08005696 | Director | 21 Nov 2024 | 1 yr 11 mo | Ironsource India Private Limited |
| Jasmine De Layton DIN 10792925 | Director | 08 Jul 2025 | 1 yr 4 mo | Ironsource India Private Limited |
| Shridhar Subbaraman Iyer DIN 07151577 | Director | 30 Oct 2025 | 1 yr | Ironsource India Private Limited |
Financials of CellAegis Devices
Figures of Ironsource India Private Limited, the primary company behind CellAegis Devices, for FY 2025. Revenue was ₹21.75 Cr (+206% year on year). Net profit was ₹3.79 Cr (17% margin). EBITDA was ₹5.88 Cr (27% margin). Revenue has grown at a compounded annual rate of +87% over three years and +59% over five years.
- ₹21.75 CrRevenue · FY 2025 · +206% YoY
- ₹3.79 CrNet profit · 17% margin
- ₹5.88 CrEBITDA · 27% margin
- ₹1 LakhPaid-up capital
- 21Employees (provident fund records)
- +87%Revenue CAGR, 3 years
- +59%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Ironsource India Private Limited are on its company page.
Detailed financial statements for CellAegis Devices
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of CellAegis Devices
3 dated milestones of CellAegis Devices across 8 years, from founding to its latest funding, stage changes and deals.
- Founded CellAegis Devices is founded.
- Funding First funding round of $24K.
- Funding Latest funding round, Series C, of $9.5M.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cellaegis Devices
Complete news archive for CellAegis Devices
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CellAegis Devices
CellAegis Devices was founded in 2009 and raised its 1st funding round 4 years after it was founded.
CellAegis Devices is headquartered in Mississauga, Canada. It is registered at Mississauga, Ontario, Canada.
CellAegis Devices is a funded company, having raised a total of $19.13M across 6 funding rounds to date. The company's 1st funding round was a Seed of $23.69K, raised on Mar 2013.
The primary company behind CellAegis Devices, Ironsource India Private Limited, reported revenue of ₹21.75 Cr for FY 2025, up 206% year on year.
CellAegis Devices was founded in 2009 in Mississauga, Canada, within the medical devices sector focused on cardiology. The autoRIC device is being developed as a portable tool for delivering chronic remote ischemic conditioning to patients post-acute myocardial infarction or during cardiothoracic procedures. Point-of-care application is enabled for adults over 18. CE Mark and Health Canada approvals have been obtained, while investigational status is held in the US as of 2018.
CellAegis Devices has 3 investors. Key investors include CTI Life Sciences, MaRS Catalyst Fund, and Broadview Ventures.
CellAegis Devices operates through Ironsource India Private Limited.
The legal entities of CellAegis Devices currently have 4 directors, including Nora Sen Go, Bhagavant Bedi, Shridhar Subbaraman Iyer and others.